Business
Practice ManagementMalpractice ConsultHealth Law & Policy
Media
Case-Based Peer PerspectivesInvestigator Perspectives Medical World NewsPodcastsUrology Medical PerspectivesUTv VideosPeer ExchangeSpecial ReportVirtual Tumor BoardInsightsMedcastPeers & Perspectives
Conferences
Conference ListingConference Previews Conference Recaps
Publications
Urology Times JournalEditorial Advisory BoardUrologists in Cancer CareSupplements and Featured PublicationsClinical Forums Recaps
More
CME/CE
Resources
Begin Your Journey: Tackling BurnoutSponsored MediaLive EventsInteractive ToolsJob BoardPartnersSponsored ResourcesTreatment Landscape Evolutions

Subscribe

  • Business
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Benign Conditions
  • Benign Prostatic Hyperplasia
  • Bladder Cancer
  • Female Urology
  • Genitourinary Cancers
  • Genomic Testing
  • Hormone Therapy
  • Kidney Cancer
  • Kidney Stones
    • Challenging Anatomy
  • Men's Health
  • Next-Generation Imaging
  • OAB and Incontinence
    • Voiding Dysfunction
  • Pediatrics
  • Prostate Cancer
    • Controveries in Urologic Cancer
    • Drug Therapy
  • Sexual Dysfunction
  • UTUC
  • Urologic Surgery
    • Cosmetic Surgery
Spotlight -
Peer Exchange|
Peers and Perspectives|
Case-Based Peer Perspectives|
Urology Times Journal
Advertisement

Mitchell R. Humphreys, MD

Advertisement

Articles by Mitchell R. Humphreys, MD

Photograph courtesy of Auris Health

Robotic ureteroscopy: The future of stone management?

ByBen H. Chew, MD, MSc,Thomas Chi, MD,Manoj Monga, MD,Mitchell R. Humphreys, MD
January 21st 2020

Advances in robotic URS will help target stones and reduce ionizing radiation.

Advertisement

Latest Updated Articles

  • Photograph courtesy of Auris Health
    Robotic ureteroscopy: The future of stone management?

    Published: January 21st 2020 | Updated:



Advertisement
Advertisement

Trending on Urology Times

1

From GSM guidance to HRT reform: A landmark year for women’s health

2

What’s new at Urology on the Beach 2026

3

GPS-ProtecT study launched to validate Genomic Prostate Score in active surveillance

4

Adjusted EV-302 analysis reinforces survival advantage of EV/pembrolizumab

5

Taylor Goodstein, MD, highlights contemporary experience with gene therapies for NMIBC

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do not sell my Personnal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us